Position in SNY
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$3,920,984
+$368,673 QoQ
Shares Held
81,382
+11.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026EXENCIAL WEALTH ADVISORS, LLC holds $76,718,350 across 13 Drug Manufacturers - General names. SNY ranks #7 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
108,594 | $16,587,733 | |
| 2 | LLY |
ELI LILLY & Co
|
17,141 | $15,765,777 | |
| 3 | JNJ |
Johnson & Johnson
|
41,920 | $10,246,924 | |
| 4 | ABBV |
AbbVie Inc.
|
41,150 | $8,949,713 | |
| 5 | AMGN |
Amgen Inc
|
17,401 | $6,122,541 | |
| 6 | AZN |
Astrazeneca PLC
|
20,162 | $3,976,349 | |
| 7 | SNY |
Sanofi
This page
|
81,382 | $3,920,984 | |
| 8 | GSK |
GSK plc
|
55,198 | $3,046,377 |
All Filings in SNY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,920,984 | 81,382 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $3,552,311 | 73,304 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $3,141,301 | 66,553 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $3,065,076 | 63,446 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $3,352,667 | 60,452 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,831,631 | 58,711 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,395,213 | 58,914 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $2,710,230 | 55,858 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,772,630 | 57,050 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,681,988 | 53,931 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,690,475 | 50,158 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,453,312 | 45,516 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $2,190,241 | 40,247 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,629,814 | 33,653 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,356,143 | 140,877 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $8,057,331 | 161,050 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $8,840,285 | 172,191 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $8,327,571 | 166,219 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $9,982,555 | 207,064 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $7,495,677 | 142,341 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,600,831 | 133,458 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $5,562,631 | 114,481 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $4,814,513 | 95,964 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,134,539 | 80,990 | Shares | Sole | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||